Global
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.

‘Decentralized Clinical Trials 2.0’ On The Horizon
The remarkable shift towards decentralized clinical trials in the last three years is a testament to how this patient-centric approach of doing research has the potential to solve multiple issues such as time, cost and low participation rates. In this first segment of a two-part article, Pink Sheet looks at how innovation in this sector has just begun and we can expect more action ahead.

WHO Plans New Body To Boost Novel TB Vaccine Efforts
The WHO’s proposed “TB Vaccine Accelerator council” will focus on the need for firm political and funding commitments, drawing on the high-level coordination that helped in the rapid development of COVID-19 vaccines.

New WHO Multidisciplinary Panel To Advise On Clinical Trial Best Practices
A new WHO technical advisory group will help deliver the ambitions of the World Health Assembly’s 2022 resolution to strengthen global coordination on how clinical trials are conducted, evaluated and reported.

WHO Proposes Regulatory Flexibilities For Testing MAbs Against Infectious Diseases
A draft guideline from the World Health Organization intends to clarify regulatory expectations for the assessment of mAbs used for preventing and treating infectious diseases in health emergencies and to help with international harmonization efforts in this field.

ICH Proposes Harmonized Bioequivalence Standards For Solid Oral Drugs
The first document of a three-part series of ICH guidelines on conducting bioequivalence studies for orally administered immediate-release solid oral dosage forms has been issued for stakeholder consultation.

Ethiopian Regulators To Take Part In Work Of European Pharmacopoeia
Ethiopia is the latest African country that the European Pharmacopoeia Commission has accepted as an observer.

Global Pharma Guidance Tracker – December 2022
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Global Pharma Guidance Tracker – November 2022
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Countries To Discuss Pandemic Treaty Next Year Amid Industry Concern
A World Health Organization negotiating body has agreed to develop a “zero draft” of the proposed pandemic treaty for discussion at a meeting of WHO member states in February next year. But the international pharmaceutical industry has reiterated its concerns about some of the proposals being put forward.

Novel Vaccines Among Wide-Ranging EU Plans To Boost Health Threat Preparedness
Two documents published by the European Commission outline proposals to prepare for future health emergencies such as pandemics and the impact of antimicrobial resistance, with next-generation vaccines and novel or repurposed therapeutics high on the agenda.
Pharma Firms Must Act On Biodiversity Footprinting To Avoid Business Risks
Biodiversity footprinting may still be a new concept for pharmaceutical companies, but they need to put a clear supply chain strategy in place now, particularly as the COP 15 conference in December is expected to discuss mandatory reporting of biodiversity risks, says Luka Brown.

Stakeholders Gather To Discuss Pandemic Response And Next Steps
As Europe’s health emergency body HERA approaches its first anniversary, an unprecedented range of stakeholders including industry bodies will be meeting in December to discuss HERA’s achievements, while a separate event will showcase the next generation of vaccines for COVID-19 and other infections.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.